Cell Death Dis. 2014 Sep 4;5:e1404. doi: 10.1038/cddis.2014.364.
Latini L1, Bisicchia E1, Sasso V1, Chiurchiù V2, Cavallucci V1, Molinari M1, Maccarrone M3, Viscomi MT1.
1Santa Lucia Foundation, IRCCS 65, Rome, Italy.
2 Santa Lucia Foundation, IRCCS 65, Rome, Italy Faculty of Veterinary Medicine, University of Teramo, Teramo, Italy.
3 Santa Lucia Foundation, IRCCS 65, Rome, Italy Center of Integrated Research, School of Medicine, Campus Bio-Medico University of Rome, Rome, Italy.
Spinal cord injury (SCI) is a devastating condition of CNS that often results in severe functional impairments for which there are no restorative therapies. As in other CNS injuries, in addition to the effects that are related to the primary site of damage, these impairments are caused by degeneration of distal regions that are connected functionally to the primary lesion site. Modulation of the endocannabinoid system (ECS) counteracts this neurodegeneration, and pharmacological modulation of type-2 cannabinoid receptor (CB2R) is a promising therapeutic target for several CNS pathologies, including SCI. This study examined the effects of CB2R modulation on the fate of axotomized rubrospinal neurons (RSNs) and functional recovery in a model of spinal cord dorsal hemisection (SCH) at the cervical level in rats. SCH induced CB2R expression, severe atrophy, and cell death in contralateral RSNs. Furthermore, SCH affected molecular changes in the apoptotic cascade in RSNs - increased cytochrome c release, apoptosome formation, and caspase-3 activity. CB2R stimulation by its selective agonist JWH-015 significantly increased the bcl-2/bax ratio, reduced cytochrome c release, delayed atrophy and degeneration, and improved spontaneous functional recovery through ERK1/2 inactivation. These findings implicate the ECS, particularly CB2R, as part of the endogenous neuroprotective response that is triggered after SCI. Thus, CB2R modulation might represent a promising therapeutic target that lacks psychotropic effects and can be used to exploit ECS-based approaches to counteract neuronal degeneration.